. "1213-8711" . . "RIV/00179906:_____/11:10109084!RIV12-MZ0-00179906" . . "Recent experimental and clinical studies support the fact that bioecological intestina control with early enteral nutrition enriched with synbiotics may reduce systemic inflammation, improve the immunological status of the intestinal mucosa and help prevent infections in critically ill patients. Three prebiotics, oligofructose, galactooligosaccharides and lactulose are able to modify the balance of intestina microbiota. It appears that treatment with synbiotics during critical illness should restore the balance of microbial communities in a beneficial way with positive effects on intestinal permeability and bacterial translocation. Only data from small trials are currently available to support use of prebiotics and synbiotics in the treatment of different clinical scenarios. There is a growing evidence for the effectiveness of probiotics in inflammatory bowel disease, chronic constipation, and diverticular disease (depending on the strain used), laktose intolerance, food allergy and related metabolic disorders including diabetes mellitus."@en . "V\u00FDznam prebiotik v potrav\u011B"@cs . "4"^^ . . . . "Prebiotika jsou nestraviteln\u00E9 l\u00E1tky, jejich\u017E konzumace m\u00E1 p\u0159\u00EDzniv\u00FD fyziologick\u00FD \u00FA\u010Dinek na hostitele selektivn\u00ED stimulac\u00ED r\u016Fstu nebo aktivity n\u011Bkter\u00FDch kmen\u016F st\u0159evn\u00ED mikrofl\u00F3ry. Jsou p\u0159irozen\u011B obsa\u017Eena v n\u011Bkter\u00FDch potravin\u00E1ch (ovoce, zelenina, lu\u0161t\u011Bniny, cere\u00E1ln\u00ED v\u00FDrobky apod.), n\u011Bkter\u00E1 se vyr\u00E1b\u011Bj\u00ED pr\u016Fmyslov\u011B. Mezi hlavn\u00ED oligosacharidy, u kter\u00FDch byl prok\u00E1z\u00E1n prebiotick\u00FD efekt, a kter\u00E9 jsou dostupn\u00E9 ve vyu\u017Eiteln\u00E9 kvantit\u011B, pat\u0159\u00ED fruktooligosacharidy, trans-galaktooligosacharidy a laktul\u00F3za. Prebiotika s v\u00FDhodou kombinujeme s probiotiky, tj. \u017Eiv\u00FDmi mikroorganizmy, kter\u00E9 aplikov\u00E1ny v p\u0159im\u011B\u0159en\u00E9m mno\u017Estv\u00ED p\u0159\u00EDzniv\u011B ovliv\u0148uj\u00ED zdravotn\u00ED stav hostitele. Pat\u0159\u00ED mezi n\u011B hlavn\u011B bakterie, produkuj\u00EDc\u00ED kyselinu ml\u00E9\u010Dnou (lactobacilli, streptococci, enterococci, lactococci, bifidobacteria). Prebiotika jsou vyu\u017E\u00EDv\u00E1na s c\u00EDlem zv\u00FD\u0161it odolnost k infekc\u00EDm, p\u0159i dr\u00E1\u017Ediv\u00E9m tra\u010Dn\u00EDku, chronick\u00FDch onemocn\u011Bn\u00EDch st\u0159eva (nespecifick\u00E9 st\u0159evn\u00ED z\u00E1n\u011Bty, rakovina tra\u010Dn\u00EDku), lakt\u00F3zov\u00E9 intoleranci, potravinov\u00E9 alergii, ale i z cel\u00E9 \u0159ady dal\u0161\u00EDch indikac\u00ED jako je obezita a s n\u00ED sdru\u017Een\u00E9 metabolick\u00E9 poruchy v\u010Detn\u011B diabetes mellitus 2. typu. Pou\u017Eit\u00ED prebiotik pat\u0159\u00ED mezi p\u0159\u00EDstupy vyu\u017E\u00EDvaj\u00EDc\u00ED v\u00FD\u017Eivu a jej\u00ED komponenty v l\u00E9\u010Db\u011B chorob, je atraktivn\u00ED, modern\u00ED, a z pohledu pacienta nepochybn\u011B \u0161etrn\u00E9."@cs . "V" . . . "Prebiotika jsou nestraviteln\u00E9 l\u00E1tky, jejich\u017E konzumace m\u00E1 p\u0159\u00EDzniv\u00FD fyziologick\u00FD \u00FA\u010Dinek na hostitele selektivn\u00ED stimulac\u00ED r\u016Fstu nebo aktivity n\u011Bkter\u00FDch kmen\u016F st\u0159evn\u00ED mikrofl\u00F3ry. Jsou p\u0159irozen\u011B obsa\u017Eena v n\u011Bkter\u00FDch potravin\u00E1ch (ovoce, zelenina, lu\u0161t\u011Bniny, cere\u00E1ln\u00ED v\u00FDrobky apod.), n\u011Bkter\u00E1 se vyr\u00E1b\u011Bj\u00ED pr\u016Fmyslov\u011B. Mezi hlavn\u00ED oligosacharidy, u kter\u00FDch byl prok\u00E1z\u00E1n prebiotick\u00FD efekt, a kter\u00E9 jsou dostupn\u00E9 ve vyu\u017Eiteln\u00E9 kvantit\u011B, pat\u0159\u00ED fruktooligosacharidy, trans-galaktooligosacharidy a laktul\u00F3za. Prebiotika s v\u00FDhodou kombinujeme s probiotiky, tj. \u017Eiv\u00FDmi mikroorganizmy, kter\u00E9 aplikov\u00E1ny v p\u0159im\u011B\u0159en\u00E9m mno\u017Estv\u00ED p\u0159\u00EDzniv\u011B ovliv\u0148uj\u00ED zdravotn\u00ED stav hostitele. Pat\u0159\u00ED mezi n\u011B hlavn\u011B bakterie, produkuj\u00EDc\u00ED kyselinu ml\u00E9\u010Dnou (lactobacilli, streptococci, enterococci, lactococci, bifidobacteria). Prebiotika jsou vyu\u017E\u00EDv\u00E1na s c\u00EDlem zv\u00FD\u0161it odolnost k infekc\u00EDm, p\u0159i dr\u00E1\u017Ediv\u00E9m tra\u010Dn\u00EDku, chronick\u00FDch onemocn\u011Bn\u00EDch st\u0159eva (nespecifick\u00E9 st\u0159evn\u00ED z\u00E1n\u011Bty, rakovina tra\u010Dn\u00EDku), lakt\u00F3zov\u00E9 intoleranci, potravinov\u00E9 alergii, ale i z cel\u00E9 \u0159ady dal\u0161\u00EDch indikac\u00ED jako je obezita a s n\u00ED sdru\u017Een\u00E9 metabolick\u00E9 poruchy v\u010Detn\u011B diabetes mellitus 2. typu. Pou\u017Eit\u00ED prebiotik pat\u0159\u00ED mezi p\u0159\u00EDstupy vyu\u017E\u00EDvaj\u00EDc\u00ED v\u00FD\u017Eivu a jej\u00ED komponenty v l\u00E9\u010Db\u011B chorob, je atraktivn\u00ED, modern\u00ED, a z pohledu pacienta nepochybn\u011B \u0161etrn\u00E9." . . "Bl\u00E1ha, Vladim\u00EDr" . "The role of prebiotics in the nutrition"@en . "10" . "241197" . "Practicus" . "2"^^ . "8" . . "The role of prebiotics in the nutrition"@en . "CZ - \u010Cesk\u00E1 republika" . "V\u00FDznam prebiotik v potrav\u011B"@cs . . "V\u00ED\u0161ek, Jakub" . . . . "2"^^ . "RIV/00179906:_____/11:10109084" . "V\u00FDznam prebiotik v potrav\u011B" . . "[2286707B1389]" . . "nutrition; gut microflora; prebiotics"@en . "V\u00FDznam prebiotik v potrav\u011B" .